CDK14
Cyclin-dependent kinase 14
Also known as: CDK14_HUMAN, PFTAIRE1, PFTK1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94921
- Gene
- CDK14
- Ensembl
- ENSG00000058091
- Chromosome
- 7
- Canonical length
- 469 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables cyclin binding activity and cyclin-dependent protein serine/threonine kinase activity. Involved in G2/M transition of mitotic cell cycle and regulation of canonical Wnt signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane. Part of cytoplasmic cyclin-dependent protein kinase holoenzyme complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
469 residues, UniProt reviewed canonical sequence.
>O94921|CDK14
1 MCDLIEPQPA EKIGKMKKLR RTLSESFSRI ALKKDDTTFD EICVTKMSTR NCQGMDSVIK
61 PLDTIPEDKK VRVQRTQSTF DPFEKPANQV KRVHSENNAC INFKTSSTGK ESPKVRRHSS
121 PSSPTSPKFG KADSYEKLEK LGEGSYATVY KGKSKVNGKL VALKVIRLQE EEGTPFTAIR
181 EASLLKGLKH ANIVLLHDII HTKETLTLVF EYVHTDLCQY MDKHPGGLHP DNVKLFLFQL
241 LRGLSYIHQR YILHRDLKPQ NLLISDTGEL KLADFGLARA KSVPSHTYSN EVVTLWYRPP
301 DVLLGSTEYS TCLDMWGVGC IFVEMIQGVA AFPGMKDIQD QLERIFLVLG TPNEDTWPGV
361 HSLPHFKPER FTLYSSKNLR QAWNKLSYVN HAEDLASKLL QCSPKNRLSA QAALSHEYFS
421 DLPPRLWELT DMSSIFTVPN VRLQPEAGES MRAFGKNNSY GKSLSNSKHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDK14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 32 nTPM
- cerebellum: 20 nTPM
- hippocampal formation: 19 nTPM
- kidney: 19 nTPM
- amygdala: 18 nTPM
- retina: 16 nTPM
Single-cell type
- retinal horizontal cells: 1,302 nCPM
- neutrophils: 1,015 nCPM
- distal convoluted tubule cells: 797 nCPM
- transitional alveolar cells: 785 nCPM
- plasma cells: 738 nCPM
- neutrophil progenitors: 726 nCPM
Immune cell
- basophil: 9.1 nTPM
- memory B-cell: 8.5 nTPM
- naive B-cell: 4.8 nTPM
- neutrophil: 4.8 nTPM
- myeloid DC: 0.8 nTPM
- intermediate monocyte: 0.6 nTPM
Brain region
- cerebral cortex: 98 nTPM
- white matter: 75 nTPM
- thalamus: 74 nTPM
- midbrain: 73 nTPM
- hippocampal formation: 66 nTPM
- cerebellum: 57 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.28
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- G2/M transition of mitotic cell cycle
- regulation of canonical Wnt signaling pathway
- regulation of cell cycle phase transition
- Wnt signaling pathway
Molecular functions
- ATP binding
- cyclin binding
- cyclin-dependent protein serine/threonine kinase activity
- protein serine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDK14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDK14 as an antibody target. Whether an autoantibody or antibody against CDK14 could matter depends on whether native CDK14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDK14 is annotated at the cell surface, where native CDK14 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CDK14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...